# FDA Inspection 992723 - Granules India Limited - October 14, 2016

Source: https://www.keypedia.com/records/fda_inspections/granules-india-limited/51f8ec49-5cc9-4bbf-8649-01781483fec3
Source feed: FDA_Inspections

> FDA Inspection 992723 for Granules India Limited on October 14, 2016. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 992723
- Company Name: Granules India Limited
- Inspection Date: 2016-10-14
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1248503 - 2024-09-06](https://www.keypedia.com/records/fda_inspections/granules-india-limited/fafbbf18-17ed-4ac4-bd8a-6d8705e8c706)
- [FDA Inspection 1118644 - 2020-02-14](https://www.keypedia.com/records/fda_inspections/granules-india-limited/e944d7ad-7bc6-4e13-834e-8dd487037e68)
- [FDA Inspection 1050607 - 2018-03-23](https://www.keypedia.com/records/fda_inspections/granules-india-limited/1db8ee74-e589-4a94-81f5-9692355dcaa2)
- [FDA Inspection 918291 - 2015-03-13](https://www.keypedia.com/records/fda_inspections/granules-india-limited/f23dcce6-2e97-4571-a280-10165728f3fe)
- [FDA Inspection 801724 - 2012-09-13](https://www.keypedia.com/records/fda_inspections/granules-india-limited/63647fb3-e1ef-4b06-9c8c-94651cf887f9)

Company: https://www.keypedia.com/companies/granules-india-limited/e2f27ea6-6e3b-4432-a874-d34393d76014

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c